Literature DB >> 8982829

Influence of immunoglobulin and interleukin 2 on the translocation of microorganisms from gut into blood.

J Seifert1, D Nitsche, H Gröper.   

Abstract

The aim of this study was to influence the translocation of microorganisms and endotoxin from the gut of septic rats by the intravenous (i.v.) administration of immunoglobulin and interleukin 2. Acute infection was induced in all animals by an intraperitoneal bacterial challenge of 2 x 10(6) microorganisms (Ps. aeruginosa, E. coli, Kleb. pneumoniae). Immediately after the bacterial challenge control animals were given albumin i.v. whereas the experimental groups were given immunoglobulin or interleukin 2. A significant reduction of bacteria in the plasma of rats was observed in immunoglobulin treated animals (10,000 CFU/ml vs 450 CFU/ml). This was accompanied by an increase of plasma endotoxin of nearly 100% within the first 2 h. Interleukin 2 essentially did not change the bacterial count in comparison with albumin-treated control animals but reduced the endotoxin level in plasma up to tenfold. It is concluded that both immunoglobulins and interleukin 2 are involved in severe infections. Whereas immunoglobulins reduce bacterial translocation, interleukin 2 stimulates the elimination of endotoxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982829      PMCID: PMC1167696     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  6 in total

Review 1.  Role of the gut in multiple organ failure: bacterial translocation and permeability changes.

Authors:  G M Swank; E A Deitch
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

2.  IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis.

Authors:  K N Haque; M H Zaidi; H Bahakim
Journal:  Am J Dis Child       Date:  1988-12

3.  Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.

Authors:  I Schedel; U Dreikhausen; B Nentwig; M Höckenschnieder; D Rauthmann; S Balikcioglu; R Coldewey; H Deicher
Journal:  Crit Care Med       Date:  1991-09       Impact factor: 7.598

4.  Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria.

Authors:  K T Chong
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

5.  Increased intestinal permeability in endotoxic pigs. Mesenteric hypoperfusion as an etiologic factor.

Authors:  M P Fink; J B Antonsson; H L Wang; H R Rothschild
Journal:  Arch Surg       Date:  1991-02

6.  Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.